Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program
Michael Roth(The University of Texas MD Anderson Cancer Center), David R. Freyer(University of Southern California), Anne‐Marie Langevin(Albert Einstein College of Medicine), Brad H. Pollock(University of California, Davis), Ann M. O’Mara(National Cancer Institute), David S. Dickens(Albert Einstein College of Medicine), Nita L. Seibel(National Cancer Institute)
Cited by 77
Related Papers
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|1999|1.2k
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JNCI Journal of the National Cancer Institute|2014|1.1k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JAMA Oncology|2015|1k
Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2012|433